• English
  • Français
Bladder Cancer CanadaBladder Cancer CanadaBladder Cancer CanadaBladder Cancer Canada
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal Surgery
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate
NextPrevious

Top 5 Bladder Cancer Breakthroughs in Canada

By Bladder Cancer Canada | Latest news and stories | 7 May, 2021 | 0

1. Bladder Cancer Canada has identified awareness and outreach to be a critical priority in 2021. We know that 80,000 Canadians are living with bladder cancer and that our community base consists of approximately 10% of these patients. BCC is strategizing new communications and awareness initiatives to target newer audiences that currently may not be aware of BCC or even bladder cancer in general. This includes the launch of a bladder cancer blog in December of 2020 and a podcast for Bladder Cancer Awareness Month in May 2021. BCC also continues to discover impactful stories of young patients through social media, particularly Facebook and Instagram, which is helping us reach a much younger Canadian demographic.

2. Many pharmaceutical companies that collaborate and keep in dialogue with Bladder Cancer Canada continue to make great progress in improving the quality of care for bladder cancer patients in Canada. Most recently, this includes Health Canada’s approval of Verity Pharmaceuticals’ production and distribution of the BCG Russian strain (which will be available to Canadians this year), as well as the approval of EMD Serono/Pfizer’s Avelumab as maintenance therapy in Metastatic Bladder Cancer. Bladder Cancer Canada worked closely with these pharmaceutical companies in the distribution of this important information to our patient community, and providing BCC spokespeople and patient stories for media opportunities, as requested. BCC also worked with AstraZeneca on the New Normal Same Cancer campaign, to raise awareness amongst Canadians that their cancer advocacy efforts, treatment and care must continue despite the global impact of COVID-19.

3. Despite the impact and challenges of the COVID pandemic, the Bladder Cancer Forum with the Canadian Clinical Research Group was held virtually in Canada in February 2021, following two other translational research meetings held in 2020 (April and October). This forum will be the foundational work of the Canadian Bladder Cancer Research Network, which launched in April 2020.

4. Canada is showing great progress in organ preservation for bladder cancer, through two international trials, one on BCG unresponsive disease (Dr. Peter Black) and the other on bladder preservation for muscle invasive disease (Dr. Wes Kassouf).

5. Bladder Cancer Canada continues to fund research as one of its three organizational pillars. Bladder Cancer Canada’s research grants are funding the following two studies: ctDNA-FGFR status as a predictive biomarkerfor FGFR targeted therapy (Dr. Bernie Eigl) and Computer-aided Discovery of a Specific Inhibitor of Notch-2 in Bladder Cancer (Dr. Peter Black). The following two research studies are also being funded by Bladder Cancer Canada, in partnership with the Canadian Urological Association Scholarship Foundation: Exploring the tumour immune environment of bladder cancer (Dr. Robert Siemens, Tizianna Cotechini, Charles Hindmarch and Parvin Mousavi) and Role of bisphenol compounds (BPA and BPS) in the progression of bladder cancer (Drs. Stephane Bolduc, Martin Pelletier, Frederic Pouliot). Bladder Cancer Canada is allocating $100K for research grants in 2021, which will be matched by the Canadian Urological Association (CUA) for a total of $200K. These funds will be divided into four $25K grants and two $50K grants adjudicated by a panel of peers.

No tags.

Related Post

  • Volunteer’s personal approach leads to deeper commitment from corporate supporter

    By Bladder Cancer Canada | 0 comment

    By: Tom Eremondi Read time: 3.5 minutes Admittedly old school, Gerry Ross’ approach to dealing with a local walk sponsor nurtured and enhanced the relationship to a surprising level. This story, however, dates back aboutRead more

  • “The risk of recurrence of my cancer is high, so I need to take care of myself.”

    By Bladder Cancer Canada | 0 comment

    Read time: 2 minutes We were so pleased to see one of our new Peer Support Volunteers, Gervais  Fournier, featured in this New Normal, Same Cancer news story, seen last month in the Le JournalRead more

  • This May, we’re making bladder cancer impossible to ignore! 

    By Bladder Cancer Canada | Comments are Closed

    Subscribe today! Our May newsletter is filled with lots of initiatives to create awareness for bladder cancer including blogs, podcasts, helpful facts, webinars and more. Bladder cancer is the 5th most common cancer in Canada andRead more

  • Bladder cancer & COVID-19 FAQ

    By Bladder Cancer Canada | Comments are Closed

    Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way aboutRead more

  • Protecting Yourself During the Coronavirus Outbreak

    By Bladder Cancer Canada | Comments are Closed

    (The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more

  • Health Canada Approves BALVERSA

    By Bladder Cancer Canada | Comments are Closed

    In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more

  • Patient Story: Ann

    By Bladder Cancer Canada | Comments are Closed

    I was diagnosed with bladder cancer after a significant amount of blood appeared in my urine.

  • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 

    By Bladder Cancer Canada | Comments are Closed

    We have developed this easy-to-understand resource aimed at increasing awareness of hematuria.

  • Our First Annual Research Report Is Live! 

    By Bladder Cancer Canada | Comments are Closed

    Our first Annual Research Report brings you exciting updates from the world of bladder cancer research.

  • Tax Season is Upon Us! 

    By Bladder Cancer Canada | Comments are Closed

    Spring has sprung and so has tax season! Don’t miss out on valuable credits or deductions! 

  • Happy National Volunteer Week 2025!

    By Bladder Cancer Canada | Comments are Closed

    National Volunteer Week is celebrated annually to honour all the volunteers who make a powerful impact.

Leave a Comment

Cancel reply

Your email address will not be published. Required fields are marked *

NextPrevious

Recent Blog Posts

  • Patient Story: Ann
  • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 
  • Our First Annual Research Report Is Live! 
  • Economic Impacts of a Cancer Diagnosis on Canadians
  • Tax Season is Upon Us! 

Upcoming Events

  • Outreach Events
  • In-person Education Events
  • Support Groups
  • Webinars

Blog Categories

  • Blog
  • Honouring our volunteers
  • Latest news and stories
  • Patient Stories
  • Upcoming meeting and events
  • Volunteers
  • Webinar

Bladder Cancer Canada

4936 Yonge Street, Suite 1000, Toronto, ON M2N 6S3
Phone: 1-866-674-8889
Email & Media Contact: info@bladdercancercanada.org

Privacy Policy | Donor Bill of Rights

Charitable Reg No. 83612 6060 RR0001

© Bladder Cancer Canada.

SUBSCRIBE TO OUR NEWSLETTER
SEND US A MESSAGE
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal Surgery
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate
Bladder Cancer Canada